PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that the entire staff from Compass Strategic Consulting (Compass) has joined Certara’s Evidence & Access group. Certara Evidence & Access was formed through the acquisition of Analytica Laser (market access, health economics and real-world […]
The latest version of ActivityBase and ActivityBase XE version 9.5 has been released to customers. This forms part of IDBS’ regular bi-annual product release and continues our investment into ActivityBase, supporting our large top pharma and biotech customer base. Over the past few releases IDBS has added offerings to enable collaborations between pharma/biotech and CROs, reduced product […]
From the inception of the company, HitGen has been utilizing Scilligence’s Electronic Laboratory Notebook (ELN) and RegMol system to capture and manage the large volume of DEL (DNA-encoded libraries) and their drug discovery project data. “I was very impressed by the CEO of HitGen Dr. Jin Li’s vision that he would establish an integrated informatics […]
Amended agreement follows positive results in corn stalk rot fungal disease control Rehovot, Israel – Evogene Ltd. (NASDAQ, TASE: EVGN) a leading biotechnology company developing novel products for life science markets, announces today that after achieving positive results, its corn disease resistance research collaboration with the Crop Science Division of Bayer[1] is being refocused on the […]
QuartzBio™, part of Precision for Medicine, Expands Computational Biology and Launches Boston Office
NEW BOSTON TEAM PROVIDES BIOTECH CLIENTS WITH MULTIOMIC BIOMARKERS, CHARACTERIZATION OF DISEASE BIOLOGY, AND MECHANISM OF ACTION ANALYSIS BOSTON, MA – QuartzBio™, part of Precision for Medicine, today announced a significant expansion of its computational biology and multiomic data integration capabilities through the launch of a Boston-based office. The new office is one of many recent investments […]
Simulations Plus today announced that it has entered into a new 5-year Research Collaboration Agreement with the FDA’s Center for Veterinary Medicine. Center for Veterinary Medicine to apply GastroPlus® to assess product bioequivalence in canines Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer […]
CDD Awarded Phase 1 SBIR Grant on an Intelligent Chemical Structure Browser for Drug Discovery and Optimization Burlingame, California — Collaborative Drug Discovery, provider of CDD Vault web-based drug discovery informatics platform, announced they won a competitive, peer-reviewed Phase 1 SBIR grant from NIH NCATS, titled: “Novel Deep Learning Strategy to Better Predict Pharmacological Properties of […]
NEW YORK – Schrödinger today announced receipt of a milestone payment from Ono Pharmaceutical Co., Ltd.(“Ono”) as part of a collaboration leveraging Schrödinger’s advanced computational platform to develop novel therapeutic candidates acting on the therapeutic target selected by Ono. To advance the program, Schrödinger deployed its reaction-based enumeration tools and machine-learning technologies to identify and filter millions […]
Milestone marks advancement of second drug discovery program under the collaboration NEW YORK – Schrödinger today announced receipt of a preclinical milestone payment from Sanofi in a drug discovery program advancing as part of a multi-year, multi-target collaboration between the two companies. Under the terms of the collaboration, Schrödinger provides advanced molecular simulation and computational design expertise […]
Next-generation global data platform to advance development of bio-based solutions and fermentation processes RESEARCH TRIANGLE PARK, NC, July 10, 2019 – To advance its development of bio-based solutions and fermentation processes using digital technologies, BASF is collaborating with Riffyn on its global experiment data capture platform. BASF will integrate its white biotechnology research tools and […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
